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Original ArticleQuantification of atherosclerotic plaque volume in coronary arteries
by computed tomographic angiography in subjects with and
without diabetesZhi-Hui Hou1, Bin Lu1, Zhen-Nan Li1, Yun-Qiang An1, Yang Gao1, Wei-Hua Yin1, Matthew J. Budoff2
1Department of Radiology, Fu Wai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100037, China;
2Division of Cardiology, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA.Abstract
Background: Diabetes mellitus (DM) is considered a cardiovascular risk factor. The aim of this study was to analyze the prevalence
and volume of coronary artery plaque in patients with diabetes mellitus (DM) vs. those without DM.
Methods: This study recruited consecutive patients who underwent coronary computed tomography (CT) angiography (CCTA)
betweenOctober 2016 andNovember 2017. Personal information including conventional cardiovascular risk factors was collected.
Plaque phenotypes were automatically calculated for volume of different component. The volume of different plaque was compared
between DM patients and those without DM.
Results: Among 6381 patients, 931 (14.59%) were diagnosed with DM. The prevalence of plaque in DM subjects was higher
compared with nondiabetic group significantly (48.34% vs. 33.01%, x2= 81.84, P< 0.001). DM was a significant risk factor for
the prevalence of plaque in a multivariate model (odds ratio [OR]= 1.465, 95% CI: 1.258–1.706, P< 0.001). The volume of total
plaque and any plaque subtypes in the DM subjects was greater than those in nondiabetic patients significantly (P< 0.001).
Conclusion: The coronary artery atherosclerotic plaques were significantly higher in diabetic patients than those in non-diabetic
patients.
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Diabetes mellitus (DM) is considered a cardiovascular risk
factor, and the rate of cardiac events in people with diabetes
is 2 to 3 fold higher compared with that in patients without
DM.[1-4] Several investigations have indicated that DM
patients without a history of cardiovascular events have a
similar chance for myocardial infarction as compared to
non-DM patients with previous coronary events.[1-4]
Coronary artery calcium (CAC) is a valuable method to
assess coronary heart disease risk in diabetic patients.[5,6]
However, little is known with insight into fully quantified
plaque in patients with DM. Recent advancement in
noninvasive computed tomography (CT)-based plaque
imaging makes it possible to classify atherosclerotic plaque
components and to quantify plaque volume.
There are few large cohort studies to fully quantified
plaque component and volume in patients with DM.Access this article online
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773Methods
Ethical approval
The study was approved by the Ethics Committee of Fu
Wai Hospital, and all patients provided informed consent
for inclusion in the registry.Patient population
We recruited 6676 consecutive patients referred for
coronary CT angiography (CCTA) by their cardiologists
between October 2016 and November 2017. Exclusion
criteria were for the subjects who had insufficient clinical
data (n= 212), non-diagnostic coronary images (n= 45),
had an acute coronary syndrome (n= 38). Data of 6381
patients were collected for final analysis [Figure 1] and
were divided into two groups (n= 931 patients with DM;
n= 5450 without DM) according to the American
Diabetes Association criteria.[7]Correspondence to: Prof. Bin Lu, Department of Radiology, Fu Wai Hospital, Peking
Union Medical College and Chinese Academy of Medical Sciences, #167 Bei Li Shi
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First, patients underwent non-enhanced scan to measure
the calcium score. CCTA was performed, thereafter, using
prospective electrocardiogram (ECG) gating. A double-
head power injector was used to inject contrast media. The
scanning parameters were as follows: 0.6 mm individual
detector width; 280 ms gantry rotation time; 0.20 to 0.50
pitch; 200 to 250 mm field of view for raw image
reconstruction. All the scans were analyzed on the
workstation (ADW4.6, GE Healthcare, Milwaukee, WI,
USA) by two radiologists. Calcium was defined as the
presence of at least three pixels with a density of>130HU.
The coronary artery tree was segmented according to the
modified American Heart Association classification. We
classified coronary plaques by calcified and non-calcified
components and quantified their volumes automatically
according to Hounsfield unit thresholds.[8,9] Non-calcified
plaque volume was further split by lipid and fibrous plaque
volumes. Total plaque was summed up by different
component plaque volume.
Clinical data
Obesity was defined as body mass index (BMI) greater
than 30 kg/m2. Hypertension was defined as systolic blood
pressure >140 mmHg, diastolic blood pressure >90Figure 1: Flow chart of this cohort study recruiting 6676 consecutive patients who
underwent coronary computed tomography angiography (CCTA). DM: Diabetes mellitus.
Table 1: Baseline characteristics of all the 6381 consecutive patients u
Characteristics
Overall
(n= 6381)
DM
(n= 931)
Age (years) 55.4± 10.2 57.5± 10.0
Male, n (%) 3351 (52.52) 556 (59.72)
BMI (kg/m2) 25.47± 3.21 26.31± 3.36
Hypertension, n (%) 3188 (49.96) 549 (58.97)
Dyslipidemia, n (%) 2653 (41.58) 580 (62.30)
Family history, n (%) 2695 (42.23) 391 (42.00)
Smoking, n (%) 2076 (32.53) 353 (37.92)
Chest pain, n (%) 2652 (42.56) 391 (42.00)
DM: Diabetes mellitus; BMI: Body mass index.
774mmHg, or antihypertensive medication use. Hypercholes-
terolemia was defined according to the National Choles-
terol Education Program (NCEP) guidelines.[10] A family
history of coronary heart disease was defined as a history
of early coronary heart disease in the immediate family
(father <55 years or mother <65 years).Statistical analysis
Mann-Whitney U test and Chi-square test were used to
compare risk factors and different quantitative plaque
component volumes between the nondiabetic and diabetic
patients. Chi-square test was applied to compare the
prevalence of plaque indifferent patients. Logistic regression
was used to evaluate the association between diabetes and
the prevalenceof plaque. Statistical analyseswereperformed
with SPSS version 19.0 (SPSS® Inc., Chicago, IL, USA).Results
Overall, data of 6381 patients (3351 men and 3030
women) were collected for the final analysis, including 931
(14.59%) patients with DM, and 5450 (85.41%) without
DM [Table 1]. The traditional cardiovascular risk factors
were more pronounced in DM patients as compared to the
non-DM patients except for presence of family history.
In Table 2, 2249 (35.25%) patients (450 DM patients and
1799 nondiabetic patients) had plaque detected on CCTA.
The prevalence of plaque was significantly higher in DM
subjects compared with nondiabetic group (lipid: 47.37%
vs. 32.22%, fibrous: 48.23% vs. 33.00%, calcified:
37.92% vs. 24.97%, respectively, P< 0.001). Moreover,
the prevalence of non-calcified plaque was significantly
higher in the DM subjects (48.34% vs. 33.01%,
P< 0.001) [Table 2, Figure 2]. In the univariate analysis,
DM was a risk factor for plaque. DM remained an
independent risk factor of the presence of plaques in a
multivariate model (OR = 1.465, 95% CI: 1.258–1.706,
P< 0.001) [Table 3)].
Plaque volumes ranged from 0 to 371.1mm3 (inter quartile
range (IQR): 8.9 mm3) in lipid plaques, from 0 to 2286.0
mm3 (IQR: 92.0 mm3) in fibrous plaques, and from 0 to
326.4 mm3(IQR: 0.5 mm3) in calcified plaques, respec-
tively. The mean plaque volumes for lipid, fibrous and
calcified plaques were significantly higher in the DMnderwent coronary computed tomography angiography.
Without DM
(n= 5450) Statistics P values
55.0± 10.3 t= 2.34 0.019
2795 (51.28) x2= 22.70 <0.001
25.45± 3.41 t= 7.15 <0.001
2639 (48.42) x2= 35.38 <0.001
2073 (38.04) x2= 192.70 <0.001
2304 (42.28) x2= 0.03 0.886
1723 (31.61) x2= 14.39 <0.001
2261 (41.49) x2= 0.09 0.774
Figure 2: Maximum intensity projection (A) showed a mixed plaque (arrow) in the proximal anterior descending branch (LAD), volume rendering (B) showed the plaque caused more than
50% stenosis (arrow) in a 59-year-old female patient with diabetes mellitus (height: 1.60 m, weight: 60 kg).
Table 2: The prevalence of plaque in patients with and without DM, n (%).
Plaque Overall
(n= 6381)
DM
(n= 931)
Without DM
(n= 5450)
x2 P value
Lipid plaque 2197 (34.43) 441 (47.37) 1756 (32.22) 80.82 <0.001
Fibrous plaque 2247 (35.21) 449 (48.23) 1798 (33.00) 80.92 <0.001
Calcified plaque 1714 (26.86) 353 (37.92) 1361 (24.97) 67.81 <0.001
Non-calcified plaque 2249 (35.25) 450 (48.34) 1799 (33.01) 81.84 <0.001
Any plaque 2249 (35.25) 450 (48.34) 1799 (33.01) 81.84 <0.001
DM: Diabetes mellitus.
Table 3: Logistic regression analysis between DM and the prevalence of plaque.
Plaque Unadjusted Model Adjusted Model
OR (95% CI) P value OR (95%CI) P value
Lipid plaque 1.893 (1.644–2.179) <0.001 1.463 (1.256–1.704) <0.001
Fibrous plaque 1.892 (1.644–2.177) <0.001 1.467 (1.259–1.708) <0.001
Calcified plaque 1.836 (1.587–2.125) <0.001 1.434 (1.224–1.680) <0.001
Non-calcified plaque 1.890 (1.642–2.175) <0.001 1.465 (1.258–1.706) <0.001
Any plaque 1.890 (1.642–2.175) <0.001 1.465 (1.258–1.706) <0.001
DM: Diabetes mellitus; OR: Odds ratio.
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plaques: IQR: 25.2 mm3vs. 6.3 mm3, P< 0.001; fibrous
plaques: IQR: 171.7 mm3vs. 73.0 mm3, P< 0.001;
calcified plaques: IQR: 5.3 mm3vs. 0.1 mm3, P< 0.001).
Similar findings between the DM and non-DM groups
were also observed for non-calcified and total plaque
volume (IQR: 210.2 mm3vs. 85.6 mm3, P< 0.001; 222.2
mm3vs. 91.8mm3, P< 0.001) [Figure 3, Table 4].
Discussion
In this cross-sectional study, we found significant higher
prevalence of coronary plaques and consistently higher
plaque volumes of all the detected compositions among the
patients with DM as compared to those without DM,
which was consistent with previous studies.[11,12]
Although prior studies have rejected the theory of
equivalency of diabetes with CAD,[13] the harm that775diabetes does to cardiovascular system still cannot
ignore.[14,15] The calcification score is only a quantification
of calcified plaques, but in diabetic patients, there are a large
number of non-calcified plaques in coronary arteries.[16]
It has been shown that overall coronary plaque burden is
a better predictor of future cardiovascular events.[17] In the
past, the quantitative analysis of coronary artery plaque
mainly relied on intravascular Ultrasound (IVUS).[18]
Compared to IVUS, CT is also good at quantifying
plaque, and can be used to study large populations.[19]
We found the prevalence of any plaque in DM subjects was
remarkably high (48.34%), and DM was an independent
risk factor. Pundziute et al[20] demonstrated in patients
with diabetes, the segment of coronary artery plaque
increased significantly. In a postmortem study, Burke
et al[21] showed that patients with DM have a larger total
and distal plaque.
Figure 3: The quantified plaque volume in patients with and without DM. The lipid plaque volume (A), fibrous plaque volume (B), calcified plaque volume (C), non-calcified (D) and total
plaque volume (E) in diabetic subjects were significantly greater than non-diabetic patients (P< 0.001). DM: Diabetes mellitus.
Chinese Medical Journal 2020;133(7) www.cmj.orgPrevious study had also looked at the components of
coronary plaque in patients with DM.[22] We found
significantly greater calcified plaque volume in the DM
patients than in the nondiabetic patients. As shown in a
recent meta-analysis study of symptomatic patients
without known CAD, calcifications assessed through CT
scans are more frequent in patients with DM.[23] Similarly,776patients with diabetes were also found to have a higher
calcified plaque burden in their coronary arteries by the
Multi-Ethnic Study of Atherosclerosis (MESA).[24] Previ-
ous study had also found a significant increase in the
necrotic core and inflammatory cells of coronary plaque in
diabetic patients.[25-28] Such plaque was vulnerable plaque
that could lead to acute events. In this study, we also found
Table 4: The quantified plaque component and volume in patients with and without DM.
Plaque volume Minimum 25% Median 75% Maximum z P value
Lipid plaque
DM 0 0 0 25.2 371.1
9.930 <0.001
Without DM 0 0 0 6.3 317.7
Fibrous plaque
DM 0 0 0 171.7 2286.0
9.748 <0.001
Without DM 0 0 0 73.0 1745.8
Calcified plaque
DM 0 0 0 5.3 326.4
8.472 <0.001
Without DM 0 0 0 0.1 313.0
Non-calcified plaque
DM 0 0 0 210.2 2608.7
9.797 <0.001
Without DM 0 0 0 85.6 1857.6
Total plaque
DM 0 0 0 222.2 2627.3
9.752 <0.001
Without DM 0 0 0 91.8 2005.0
DM: Diabetes mellitus.
Chinese Medical Journal 2020;133(7) www.cmj.orgthe volumes of lipid plaque and fibrous plaque was
significantly higher in DM patients.Study limitations
High-risk characteristics in the diabetic population may be
partially influenced by daily glucose fluctuation and may
be found already in patients with an impaired glucose
tolerance.[29] However, in our study, we cannot fully
exclude impaired glucose tolerance without overt diabetes
mellitus in our non-DM group as oral glucose tolerance
testing was not performed routinely. An autopsy study
demonstrated an association between DMduration and the
extent of atherosclerosis and myocardial lesions,[30] so the
duration of DM should be considered in the future studies.
In conclusion, the coronary artery atherosclerotic plaques
were significantly higher in diabetic patients than those in
non-diabetic patients.Funding
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